This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations by John Louie in Injectable Formulations
Introduction
John Louie is an accomplished inventor based in Newark, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. With a total of 3 patents to his name, Louie's work focuses on improving treatment methods for patients requiring long-acting medications.
Latest Patents
One of Louie's latest patents is centered around dosing regimens associated with extended-release paliperidone injectable formulations. This invention provides methods for treating patients with long-acting injectable paliperidone palmitate formulations. The disclosure includes innovative methods for mitigating adverse changes in blood lipid levels in patients treated with paliperidone palmitate extended-release injectable suspension at either one-month intervals (PP1M) or three-month intervals (PP3M). The invention also outlines a transition to a paliperidone palmitate extended-release injectable suspension with a six-month dosing interval (PP6M).
Another patent by Louie also focuses on dosing regimens associated with extended-release paliperidone injectable formulations, further emphasizing his commitment to enhancing patient care through innovative pharmaceutical solutions.
Career Highlights
Louie has established a notable career at Janssen Pharmaceutica NV, where he has been instrumental in advancing research and development in the pharmaceutical industry. His expertise in injectable formulations has positioned him as a key player in the field.
Collaborations
Throughout his career, Louie has collaborated with talented professionals, including Panna Sanga and Ruth Milz. These partnerships have contributed to the successful development of his innovative patents and have fostered a collaborative environment for research and development.
Conclusion
John Louie's contributions to the field of pharmaceuticals, particularly in injectable formulations, demonstrate his dedication to improving patient outcomes. His innovative patents and collaborative efforts highlight the importance of research in advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
